BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1824983)

  • 1. Preferential activation of CD45RA+ cells by a monoclonal antibody to the alpha/beta T-cell receptor.
    Schwinzer R; Schlitt HJ; Wonigeit K
    Transplant Proc; 1991 Feb; 23(1 Pt 1):277-8. PubMed ID: 1824983
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CD45RA antibodies increase the proliferation of mouse T cells to phytohemagglutinin through the interleukin 2/interleukin 2 receptor pathway.
    Marvel J; Poirier G; Lightstone E
    Eur J Immunol; 1989 Nov; 19(11):2005-10. PubMed ID: 2532137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the CD45 antigen and phytohemagglutinin. Inhibitory effect on the lectin-induced T cell proliferation by anti-CD45 monoclonal antibody.
    Bernabeu C; Carrera AC; De Landázuri MO; Sánchez-Madrid F
    Eur J Immunol; 1987 Oct; 17(10):1461-6. PubMed ID: 2960537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory T cells express high levels of a novel leukocyte common antigen epitope identified by the A6 MAb.
    Aversa GG; Hall BM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):300-1. PubMed ID: 1703685
    [No Abstract]   [Full Text] [Related]  

  • 5. CD45-protein tyrosine phosphatase cross-linking inhibits T cell receptor CD3-mediated activation in human T cells.
    Kiener PA; Mittler RS
    J Immunol; 1989 Jul; 143(1):23-8. PubMed ID: 2525147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody.
    Ferran C; Bluestone J; Bach JF; Chatenoud L
    Transplant Proc; 1990 Aug; 22(4):1922-3. PubMed ID: 2143865
    [No Abstract]   [Full Text] [Related]  

  • 7. Different modes of T-cell activation by monoclonal antibodies to the alpha/beta T-cell receptor and the CD3 complex.
    Schlitt HJ; Schwinzer R; Wonigeit K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):147-8. PubMed ID: 2523121
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
    Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subsets and surface molecules in man.
    Krensky AM; Lanier LL; Engleman EG
    Clin Immunol Rev; 1985; 4(1):95-138. PubMed ID: 2992859
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.
    Kaye J; Janeway CA
    Lymphokine Res; 1984; 3(4):175-82. PubMed ID: 6436584
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic diversity of the CD45 antigen and its relationship to function.
    Beverley PC; Merkenschlager M; Terry L
    Immunol Suppl; 1988; 1():3-5. PubMed ID: 2968306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent activation of murine T cells following in vivo administration of anti-murine CD3.
    Ellenhorn JD; Hirsch R; Hartley JP; Bluestone JA
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1013-4. PubMed ID: 2523110
    [No Abstract]   [Full Text] [Related]  

  • 15. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to common epitopes of the human alpha/beta T-cell receptor preferentially activate CD45RA+ T-cells.
    Schwinzer R; Schlitt HJ; Wonigeit K
    Cell Immunol; 1992 Mar; 140(1):31-41. PubMed ID: 1531453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating properties.
    Vaessen LM; Kreeftenberg JG; Heyse P; Leerling MF; Baumgartner D; Hendriks GF; Jutte NH; Weimer W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1026-7. PubMed ID: 2523112
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenotypic changes and proliferative activity of human gamma delta T cell receptor-bearing cells upon activation.
    Ho S; Campana D
    Clin Exp Immunol; 1991 Jun; 84(3):376-82. PubMed ID: 1828395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interconversion of CD45R subsets of CD4 T cells in vivo.
    Bell EB; Sparshott SM
    Nature; 1990 Nov; 348(6297):163-6. PubMed ID: 1978253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
    Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
    Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.